TRANSMEDICS GROUP INC (TMDX)
US89377M1099 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-28) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 394.81M | 201.20M | 25.60M | 24.60M | 20.10M | |||
| Marketable Securities | N/A | 0.00 | 66.90M | 101.10M | 60.60M | |||
| Receivables | 63.58M | 27.60M | 5.90M | 6.90M | 6.60M | |||
| Inventories | 44.23M | 20.60M | 14.90M | 11.90M | 11.20M | |||
| Other Current Assets | 8.03M | 2.90M | 5.50M | 2.30M | 1.50M | |||
| Total Current Assets | 510.65M | 252.30M | 118.70M | 146.80M | 100.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 180.49M | 24.40M | 15.70M | 4.80M | 4.80M | |||
| Goodwill | 11.99M | N/A | N/A | N/A | N/A | |||
| Intangibles | 2.35M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 562.00K | 500.00K | 500.00K | 500.00K | 500.00K | |||
| Total Non-Current Assets | 195.39M | 24.80M | 16.20M | 5.20M | 5.30M | |||
| TOTAL ASSETS | 706.05M | 277.10M | 134.90M | 152.00M | 105.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 40.26M | 20.10M | 16.30M | 10.30M | 8.30M | |||
| Accounts Payable | 12.72M | 3.30M | 6.70M | 1.20M | 7.20M | |||
| Other Current Liabilities | 1.96M | 200.00K | 300.00K | 400.00K | 500.00K | |||
| Total Current Liabilities | 54.93M | 23.70M | 23.20M | 11.90M | 16.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 506.20M | 58.70M | 35.20M | 34.70M | 34.10M | |||
| Other Non-Current Liabilities | 7.71M | 7.40M | 8.60M | 1.60M | 400.00K | |||
| Total Non-Current Liabilities | 513.91M | 66.10M | 43.80M | 36.20M | 34.60M | |||
| TOTAL LIABILITIES | 568.85M | 89.80M | 67.00M | 48.10M | 50.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -503.70M | -478.70M | -442.40M | -398.20M | -369.50M | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 641.11M | 666.30M | 510.50M | 502.20M | 424.10M | |||
| Other Shareholders' Equity | -199.00K | -200.00K | -200.00K | -100.00K | 0.00 | |||
| Shares Outstanding | 32.67M | 32.10M | 27.80M | 27.20M | 21.20M | |||
| Tangible Book Value per Share | 3.76 | 5.84 | 2.44 | 3.82 | 2.58 | |||
| Total Shareholders' Equity | 137.20M | 187.40M | 67.90M | 103.90M | 54.60M | |||
| TOTAL LIABILITIES AND EQUITY | 706.05M | 277.10M | 134.90M | 152.00M | 105.30M | |||
| Statistics | ||||||||
| Debt/Equity | 3.69 | 0.31 | 0.52 | 0.33 | 0.62 | |||
| Current Ratio | 9.30 | 10.65 | 5.12 | 12.34 | 6.21 | |||
| Return On Assets (ROA) | -3.54% | -13.07% | -32.78% | -18.91% | -31.86% | |||
| Return On Equity (ROE) | -18.24% | -19.33% | -65.13% | -27.67% | -61.45% | |||
| Return On Invested Capital (ROIC) | 0.06% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 0.15% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 0.16% | N/A | N/A | N/A | N/A | |||
All data in USD